Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00110214 | Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | completed | Phase 3 | 1,050 | National Cancer Institute (NCI)NIH | 1 | May 9, 2014 | clinicaltrials |
| NCT00242567 | Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer | completed | Phase 3 | 522 | Novartis PharmaceuticalsINDUSTRY | 10 | May 7, 2014 | clinicaltrials |
| NCT00004001 | S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 3 | 770 | SWOG Cancer Research NetworkNETWORK | 1 | Feb 25, 2014 | clinicaltrials |
| NCT01715064 | Acute Effects of Exercise on the Cortical Silent Period in Prostate Cancer Patients | completed | Phase 2 / Phase 3 | 36 | University of Guelph-HumberOTHER | 1 | Feb 10, 2014 | clinicaltrials |
| NCT00767286 | Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | completed | Phase 3 | — | Radiation Therapy Oncology GroupNETWORK | 0 | Jan 28, 2014 | clinicaltrials |
| NCT00398281 | Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer | completed | Phase 3 | 450 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00003290 | Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 3 | 800 | Medical Research CouncilOTHER_GOV | 2 | Dec 4, 2013 | clinicaltrials |
| NCT00129142 | Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy | completed | Phase 3 | 1,200 | GTxINDUSTRY | 2 | Nov 15, 2013 | clinicaltrials |
| NCT00884273 | Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients | completed | Phase 3 | 182 | Ferring PharmaceuticalsINDUSTRY | 8 | Nov 13, 2013 | clinicaltrials |
| NCT00002703 | Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer | completed | Phase 3 | 390 | Proton Radiation Oncology GroupOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00765479 | Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer | completed | Phase 2 / Phase 3 | 284 | University of Illinois at ChicagoOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00632138 | Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate | completed | Phase 3 | 800 | Aberdeen Royal InfirmaryOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT01901042 | Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis Symptoms | completed | Phase 2 / Phase 3 | 20 | Federal University of Mato GrossoOTHER | 0 | Jul 17, 2013 | clinicaltrials |
| NCT00003367 | Diet and PSA Levels in Patients With Prostate Cancer | completed | Phase 3 | 154 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00082927 | Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain | completed | Phase 3 | 580 | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00255606 | Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer | completed | Phase 3 | 360 | Tampere UniversityOTHER | 3 | Jun 26, 2013 | clinicaltrials |
| NCT00316927 | Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer | completed | Phase 3 | 260 | St. Bartholomew's HospitalOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00182052 | Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer | completed | Phase 3 | 100 | Massachusetts General HospitalOTHER | 1 | May 23, 2013 | clinicaltrials |
| NCT01215513 | Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients | completed | Phase 3 | 127 | Ferring PharmaceuticalsINDUSTRY | 1 | May 22, 2013 | clinicaltrials |
| NCT01825642 | Prospective Randomized Trial of Seminal Vesicle-Sparing Prostatectomy and Nerve-Sparing Radical Prostatectomy in Men With Clinically Localized Prostate Cancer | completed | Phase 2 / Phase 3 | 140 | University of MichiganOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00005623 | Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer | completed | Phase 3 | — | Barr LaboratoriesINDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00451958 | A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy | completed | Phase 3 | 386 | Ferring PharmaceuticalsINDUSTRY | 12 | Mar 21, 2013 | clinicaltrials |
| NCT00002723 | Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer | completed | Phase 3 | 390 | National Cancer Institute (NCI)NIH | 2 | Feb 28, 2013 | clinicaltrials |
| NCT01071915 | Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer | completed | Phase 3 | 157 | Ferring PharmaceuticalsINDUSTRY | 1 | Feb 12, 2013 | clinicaltrials |
| NCT01174017 | Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate(FAST) | completed | Phase 3 | 41 | British Columbia Cancer AgencyOTHER | 1 | Feb 12, 2013 | clinicaltrials |
| NCT00394511 | Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate Cancer | completed | Phase 3 | 408 | National Cancer Institute (NCI)NIH | 0 | Feb 11, 2013 | clinicaltrials |
| NCT00030901 | S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate | completed | Phase 3 | 619 | SWOG Cancer Research NetworkNETWORK | 0 | Feb 6, 2013 | clinicaltrials |
| NCT00967018 | A Long Term Safety Study of Degarelix in Patients With Prostate Cancer | completed | Phase 3 | 77 | Ferring PharmaceuticalsINDUSTRY | 7 | Jan 3, 2013 | clinicaltrials |
| NCT00295750 | The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer | completed | Phase 3 | 620 | Ferring PharmaceuticalsINDUSTRY | 12 | Dec 19, 2012 | clinicaltrials |
| NCT00623090 | Internet-Based Education for Prostate Cancer Screening(PCSEd) | completed | Phase 3 | 1,893 | Georgetown UniversityOTHER | 1 | Dec 13, 2012 | clinicaltrials |
| NCT00002511 | Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer | completed | Phase 3 | 1,005 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Oct 16, 2012 | clinicaltrials |
| NCT00658229 | The Physical Exercise and Prostate Cancer Study(PEPC) | completed | Phase 3 | 60 | Oslo University HospitalOTHER | 1 | Oct 15, 2012 | clinicaltrials |
| NCT00833248 | Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer | completed | Phase 3 | 246 | Ferring PharmaceuticalsINDUSTRY | 7 | Oct 4, 2012 | clinicaltrials |
| NCT00002503 | Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases | completed | Phase 3 | 204 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Sep 24, 2012 | clinicaltrials |
| NCT00004071 | Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer | completed | Phase 2 / Phase 3 | — | PfizerINDUSTRY | 1 | Sep 11, 2012 | clinicaltrials |
| NCT00617669 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer(ENTHUSE M1C) | completed | Phase 3 | 1,494 | AstraZenecaINDUSTRY | 26 | Sep 10, 2012 | clinicaltrials |
| NCT00978718 | Selenium in Preventing Prostate Cancer | completed | Phase 3 | 700 | University of ArizonaOTHER | 0 | Aug 15, 2012 | clinicaltrials |
| NCT00003343 | Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer | completed | Phase 3 | 525 | PfizerINDUSTRY | 1 | Aug 8, 2012 | clinicaltrials |
| NCT00069745 | Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen | completed | Phase 3 | — | AgennixINDUSTRY | 15 | Aug 7, 2012 | clinicaltrials |
| NCT00849082 | Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer | completed | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Jul 11, 2012 | clinicaltrials |
| NCT00003026 | Hormone Therapy in Treating Patients With Advanced Prostate Cancer | completed | Phase 3 | 966 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 2, 2012 | clinicaltrials |
| NCT00520546 | Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer(FEC-PET/MRI) | completed | Phase 3 | 44 | Dr. Markus HartenbachOTHER | 1 | Jun 20, 2012 | clinicaltrials |
| NCT01367418 | Effects of Anesthetic Technique on Immune and Inflammatory Systems Following Radical Prostatectomy(AIMS) | completed | Phase 3 | 26 | Örebro University, SwedenOTHER | 1 | Mar 19, 2012 | clinicaltrials |
| NCT00426777 | Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer | completed | Phase 3 | 160 | CMX ResearchOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT00622973 | USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases | completed | Phase 3 | 130 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00925418 | Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer(CRYO1) | completed | Phase 3 | 168 | Institut Paoli-CalmettesOTHER | 1 | Sep 14, 2011 | clinicaltrials |
| NCT00626431 | A Study of Leuprolide to Treat Prostate Cancer | completed | Phase 3 | 310 | AbbottINDUSTRY | 1 | Jul 19, 2011 | clinicaltrials |
| NCT00270166 | The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy | completed | Phase 3 | 201 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | May 18, 2011 | clinicaltrials |
| NCT00244309 | Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer | completed | Phase 3 | 348 | Case Comprehensive Cancer CenterOTHER | 1 | May 4, 2011 | clinicaltrials |
| NCT00003115 | Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy | completed | Phase 3 | 40 | Roswell Park Cancer InstituteOTHER | 1 | Feb 23, 2011 | clinicaltrials |
Data updated 22 days agoSource updated May 9, 2014source: clinicaltrials